ライフサイエンスコーパス: total joint replacement

1 osteoarthritis (OA) synovium at the time of total joint replacement.

2 unrecognized mechanism of failure following total joint replacement.

3 oms and structural damage are candidates for total joint replacement.

4 rtilage derived from 124 patients undergoing total joint replacement.

5 ed patients had more joint safety events and total joint replacements.

6 0 patients with large joint OA who underwent total joint replacement (1,201 of whom had the nodal phe

7 For total joint replacement, a composite quality index was 5

8 ity and an approximately 2-fold reduction in total joint replacement and mortality.

9 the arcOGEN study, 80% of whom had undergone total joint replacement, and 11,009 unrelated controls f

10 nt), the role of patellar resurfacing during total joint replacement, and the use of bisphosphonates

11 tage, in which only surgical options such as total joint replacement are available.

12 In addition, the volume of total joint replacements at this center increased during

13 se of cyclooxygenase-II inhibitors, infected total joint replacements, back pain, and Lyme disease.

14 essment Questionnaire score, and presence of total joint replacement, but not by diabetes, smoking, e

15 ith advanced symptoms and structural damage, total joint replacement effectively relieves pain.

16 ation (TEM) in the BM of patients undergoing total joint replacement for osteoarthritis.

17 ting potential of developing alternatives to total joint replacement for treating osteoarthritis.

18 Total joint replacements for end-stage osteoarthritis of

19 reasingly popular due to the need for robust total joint replacement implants that have a high succes

20 ls (95% CIs) were calculated for the risk of total joint replacement in association with age, sex, bo

21 dy base consisted of patients with a primary total joint replacement in Denmark and the United Kingdo

22 ificantly higher ORs for an association with total joint replacement in nodal OA cases than in non-no

23 With the anticipated increased incidence of total joint replacement in the next decade, implant fail

24 ic prophylaxis to prevent late infections in total joint replacement is to narrow the targeted hosts

25 eumatology criteria for OA and had undergone total joint replacement or arthroscopy.

26 Despite the good clinical outcomes of total joint replacements, prosthetic joint infections st

27 ficiaries were still 14% more likely to have total joint replacement surgeries (OR 1.14 [95% CI 1.13-

28 from osteoarthritis [OA] patients undergoing total joint replacement surgery) were stimulated with cy

29 tissue bank, and from OA patients undergoing total joint replacement surgery.

30 h OA who were undergoing primary or revision total joint replacement (TJR) surgery.

31 Total joint replacement (TJR) was selected as a marker o

32 ing at least 1 opioid prescription following total joint replacements (TJRs).

33 l hip and knee replacements while increasing total joint replacement volume at this medical center.

34 The incidence of total joint replacements was 8 (3.5%), 16 (6.9%), and 4

35 ORs for total joint replacement were compared between cases of n

36 ioperative processes for patients undergoing total joint replacement were redesigned following the VA

37 Total joint replacements were reported in 8 patients: 1